TIRC7 is induced in rejected human kidneys and anti-TIRC7 mAb with FK506 prolongs survival of kidney allografts in rats

Transplant Immunology

Volumn 16, Issue 3-4, 2006, Pages 238-244

  Kumamoto, Yusuke ^a   Tamura, Akihiko ^b   Volk, Hans Dieter ^b   Reinke, Petra ^c   Löhler, Jürgen ^d   Tullius, Stefan G ^e   Utku, Nalân ^b  

^a KEIO UNIVERSITY   (Japan)

^b HUMBOLDT UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute rejection; Biopsy specimen; Combination therapy; FK506 (Tacrolimus); TIRC7

Indexed keywords

CALCINEURIN INHIBITOR; CYTOKINE; INFLIXIMAB; MONOCLONAL ANTIBODY; PROTEIN DERIVATIVE; T CELL IMMUNE RESPONSE CDNA 7; T CELL IMMUNE RESPONSE CDNA 7 ANTIBODY; TSUKUBAENOLIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MICROSCOPY, CONFOCAL; RATS; RATS, INBRED LEW; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 33751325695     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.09.027     Document Type: Article

References (20)

1. Cecka M. Clinical outcome of renal transplantation. Surg Clin North Am 78 (1998) 133-148
2. Aw M.M. Transplant immunology. J Pediatr Surg 38 (2003) 1275-1280
3. Rothstein D.M., and Sayegh M.H. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev 196 (2003) 85-108
4. First M.R. Clinical application of immunosuppressive agents in renal transplantation. Surg Clin North Am 78 (1998) 61-76
5. Wilkinson A. Progress in the clinical application of immunosuppressive drugs in renal transplantation. Curr Opin Nephrol Hypertens 10 (2001) 763-770
6. Olyaei A.J., de Mattos A.M., and Bennett W.M. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care 7 (2001) 384-389
7. Tamura A., Li X.K., Funeshima N., Enosawa S., Amemiya H., Kitajima M., et al. Immunosuppressive therapy using FTY720 combined with tacrolimus in rat liver transplantation. Surgery 127 (2000) 47-54
8. Shidban H. Induction therapy in transplantation. Curr Opin Organ Transpl 6 (2001) 320-326
9. Pascual J., Marcen R., and Ortuno J. Anti-interleukin-2 receptor antibodies: basiliximab and daclizumab. Nephrol Dial Transplant 16 (2001) 1756-1760
10. Utku N., Heinemann T., Tullius S.G., Bulwin G.C., Beinke S., Blumberg R.S., et al. Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein. Immunity 9 (1998) 509-518
11. Kumamoto Y., Tomschegg A., Bennai-Sanfourche F., Boerner A., Kaser A., Schmidt-Knossalla I., et al. Monoclonal antibody specific for TIRC7 induces donor-specific anergy and prevents rejection of cardiac allografts in mice. Am J Transplant 4 (2004) 505-514
12. Utku N., Heinemann T., Winter M., Bulwin G.C., Schlawinsky M., Fraser P., et al. Antibody targeting of TIRC7 results in significant therapeutic effects on collagen-induced arthritis in mice. Clin Exp Immunol 144 (2006) 142-151
13. Köhler G., and Milstein C. Continuous culture of fused cells secreting antibody of predefined specificity. Nature 256 (1975) 495-497
14. Heinemann T., Bulwin G.C., Randall J., Schnieders B., Sandhoff K., Volk H.D., et al. Genomic organization of the gene coding for TIRC7, a novel membrane protein essential for T cell activation. Genomics 57 (1999) 398-406
15. Smirnova A.S., Morgun A., Shulzhenko N., Silva I.D., and Gerbase-DeLima M. Identification of new alternative splice events in the TCIRG1 gene in different human tissues. Biochem Biophys Res Commun 330 3 (2005) 943-949
16. Utku N., Boerner A., Tomschegg A., Bennai-Sanfourche F., Bulwin G.C., Heinemann T., et al. TIRC7 deficiency causes in vitro and in vivo augmentation of T and B cell activation and cytokine response. J Immunol 173 4 (2004) 2342-2352
17. Tomasoni S., Azzollini N., Casiraghi F., Capogrossi M.C., Remuzzi G., and Benigni A. CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J Am Soc Nephrol 11 (2000) 747-752
18. Kita Y., Li X.K., Ohba M., Funeshima N., Enosama S., Tamura A., et al. Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4Ig-gene. Transplantation 68 (1999) 758-766
19. Kimball J.A., Pescovitz M.D., Book B.K., and Norman D.J. Reduced human IgG anti-Atgam antibody formation in renal transplantation recipients receiving mycophenolate mofetil. Transplantation 60 (1995) 1379-1383
20. Shulzhenko N., Morgun A., Rampim G.F., Franco M., Almeida D.R., Diniz R.V., et al. Monitoring of intragraft and peripheral blood TIRC7 expression as a diagnostic tool for acute cardiac rejection in humans. Hum Immunol 62 (2001) 342-347